Display Settings:

Format

Send to:

Choose Destination
    Antimicrob Agents Chemother. 2012 Feb;56(2):1135-7. Epub 2011 Nov 21.

    In vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses.

    Source

    AiCuris GmbH & Co. KG, Wuppertal, Germany.

    Abstract

    AIC246 (letermovir) is a potent anticytomegalovirus drug in clinical development. Here, we report a consistent antiviral efficacy of AIC246 against human cytomegalovirus laboratory strains, clinical isolates, and virus variants resistant to approved drugs. Furthermore, we describe a remarkable selectivity of AIC246 for human cytomegaloviruses compared to that of other alpha-, beta-, or gammaherpesviruses or nonrelated pathogenic viruses, including adeno-, hepadna-, retro-, orthomyxo-, and flaviviruses. Our data confirm and support an excellent and selective anticytomegaloviral activity of AIC246.

    PMID:
    22106211
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3264222
    [Available on 2012/8/1]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk